Skip to content

PIPAC

PROCEDURE14 trials

Sponsors

Michael Bau Mortensen, University of Leipzig, Sabine Rhode, Institut du Cancer de Montpellier - Val d'Aurelle, St. Petersburg State Pavlov Medical University

Conditions

Adenocarcinoma PancreasAdvanced Epithelial Ovarian CancerAppendix CancerAscitesCUPChemotherapeutic ToxicityChemotherapy EffectColo-rectal Cancer

Phase 1

Phase 2

Treating Peritoneal Carcinomatosis With PIPAC
CompletedNCT02320448
Michael Bau MortensenPeritoneal Carcinomatosis
Start: 2015-03-31End: 2017-08-31Updated: 2017-09-12
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
RecruitingNCT03280511
Michael Bau MortensenColo-rectal Cancer, Peritoneal Carcinomatosis, Peritoneal Metastases +1
Start: 2017-12-14End: 2027-03-01Target: 60Updated: 2022-10-06
Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -
CompletedNCT03287375
Michael Bau MortensenChemotherapeutic Toxicity, Chemotherapy Effect, Histologic Progression +4
Start: 2016-12-01End: 2022-10-01Updated: 2022-10-07
Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)
SuspendedNCT03875144
Institut du Cancer de Montpellier - Val d'AurellePeritoneal Carcinomatosis, Peritoneal Mesothelioma
Start: 2020-09-10End: 2027-06-01Target: 66Updated: 2026-02-09
Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric Study
NCT04734691
Sleiman Marwan-JulienPeritoneal Carcinomatosis
Start: 2021-10-31End: 2024-11-30Target: 50Updated: 2021-02-02
Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)
Not yet recruitingNCT06681038
Institut Cancerologie de l'OuestPeritoneal Metastases from Colorectal Cancer
Start: 2025-02-28End: 2029-08-31Target: 114Updated: 2024-11-08
Intensification Treatment of Ovarian Cancer by PIPAC
RecruitingNCT07514494
Moscow Regional Oncological DispensaryAdvanced Epithelial Ovarian Cancer, Peritoneal Carcinomatosis
Start: 2025-04-02End: 2030-04-02Target: 160Updated: 2026-04-07

Phase 3

Unknown Phase

Related Papers